Glitazone drug use by diabetic patients associated with lower risk of primary and secondary brain cancer

Diabetic patients who take anti-diabetic drugs – known as glitazones – long term had a lower risk of primary and secondary brain cancer compared with diabetic patients on other medications, new research led by the University of Bristol has found.

Study finds distinct link between sleep duration, social media usage, and brain activation in teens

A new study to be presented at the SLEEP 2024 annual meeting found a distinct relationship between sleep duration, social media usage, and brain activation

May 30, 2024

Q&A: Why medical AI and value-based care may be made for each other

At last count, the Food and Drug Administration has authorized 950 medical devices that use artificial intelligence and machine learning. But far fewer have made

September 30, 2024

Exploring the anti-cancer potential of dark tea

The potential of dark tea in cancer prevention and management.

September 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.